The DOI matches its Crossref record.
Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.
Abstract
Eight centers participated in a study in which intrapulmonary and intravenous administration of recombinant tissue-type plasminogen activator (rt-PA) were compared in 34 patients with acute massive pulmonary embolism. All patients received intravenous heparin in a bolus of 5,000 IU followed by 1,000 IU/hr. After 50 mg rt-PA given over 2 hr the severity of embolism, determined from pulmonary angiograms, declined by 12% in the intrapulmonary drug group (p less than .005) and 15% in the intravenous drug group (p less than .005); mean pulmonary arterial pressure fell from 31 +/- 7 to 22 +/- 6 mm Hg (p less than .005) and from 31 +/- 12 to 21 +/- 9 mm Hg (p less than .005) in the respective groups. After a further 50 mg given over 5 hr (22 patients), the angiographically determined severity of embolism had decreased by 38% from baseline in the intrapulmonary drug group and by 38% in the intravenous drug group. The mean pulmonary arterial pressure further declined to 18 +/- 7 and 12 +/- 5 mm Hg in the respective groups. Fibrinogen levels dropped to 48% of baseline after 50 mg and to 36% of baseline after 100 mg rt-PA. Some degree of bleeding at puncture and/or operation sites was noted in 16 patients, including four who required a transfusion of two or more units of blood and had been operated on an average of 7.5 days (range 2 to 13) before thrombolytic treatment was started.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationGuidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Jaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Antithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Self-citationGoldhaber, S. Z., Come, P. C., Lee, R. T., Braunwald, E., Parker, J. A., Haire, W. D., Feldstein, M. L., Miller, M., Toltzis, R., Smith, J. L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)90274-k · Cited by 849
Wood, K. E. (2002) · Chest · doi:10.1378/chest.121.3.877 · Cited by 718
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
(2003) · Thorax · doi:10.1136/thorax.58.6.470 · Cited by 686
Kuo, W. T., Gould, M. K., Louie, J. D., Rosenberg, J. K., Sze, D. Y., & Hofmann, L. V. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.08.002 · Cited by 504
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
Campbell, I. A., Fennerty, A., & Miller, A. C. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-4-19-39 · Cited by 458
Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90002-5 · Cited by 379
Levine, M., Hirsh, J., Weitz, J., Cruickshank, M., Neemeh, J., Turpie, A. G., & Gent, M. (1990) · Chest · doi:10.1378/chest.98.6.1473 · Cited by 308
JCS Joint Working Group (2011) · Circulation Journal · doi:10.1253/circj.cj-88-0010 · Cited by 306
Thrombolytic Therapy for Pulmonary Embolism
Kanter, D. S., Mikkola, K. M., Patel, S. R., Parker, J. A., & Goldhaber, S. Z. (1997) · Chest · doi:10.1378/chest.111.5.1241 · Cited by 275
Oates, J. A., Wood, A. J. J., Loscalzo, J., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810063191407 · Cited by 266
Metadata
- Authors
- Verstraete, M., Miller, G. A., Bounameaux, H., Charbonnier, B., Colle, J. P., Lecorf, G., Marbet, G. A., Mombaerts, P., & Olsson, C. G.
- Venue
- Circulation
- Published
- 1988-02
- Volume
- 77
- Issue
- 2
- Pages
- 353-360
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2028916703
- Cited by
- 401
- References
- 0
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.